Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs)

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Nicotinic acetylcholine receptors (nAChRs) are crucial drug targets for various human diseases.
• Structure-based drug design for nAChRs relies heavily on insights from acetylcholine binding protein (AChBP) structures.
• Current AChBP production uses eukaryotic systems, which are time-consuming and expensive.

Purpose of the Study:

• To establish a novel, cost-effective Escherichia coli (E. coli) expression system for producing functional AChBP.
• To enable simplified and faster production of AChBP for structural and biophysical studies.
• To facilitate the development of new therapeutics targeting nAChR-related disorders.

Main Methods:

• Utilized an E. coli expression system with a pHUE vector for N-terminal His-tagged ubiquitin fusion protein.
• Engineered E. coli for efficient expression of soluble, unglycosylated AChBP.
• Employed standard purification techniques to isolate functional AChBP.

Main Results:

• Achieved comparable protein yields to existing eukaryotic expression systems.
• Demonstrated that E. coli-expressed AChBP binds nAChR agonists and antagonists with expected affinities.
• Successfully produced unglycosylated AChBP suitable for crystallography and isotopically labeled forms for NMR.

Conclusions:

• The E. coli expression system significantly reduces the cost and time for AChBP production.
• This simplified system facilitates structural and biophysical studies crucial for nAChR drug development.
• The established E. coli system offers a more accessible method for obtaining functional AChBP.